Page last updated: 2024-08-22

angiotensin ii and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

angiotensin ii has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arakawa, K; Kugi, M; Matsunaga, A; Ono, J; Sasaki, J1
Fujita, T; Hirata, Y; Kitamura, T; Nagai, R; Nishimatsu, H; Omata, M; Satonaka, H; Suzuki, E; Takeda, R1
Fóris, G; Kosztáczky, B; Páll, D; Paragh, G; Seres, I; Varga, Z1
Boomsma, F; Sijbrands, EJ; van den Meiracker, AH; van der Linde, NA1
Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M1
Balogh, Z; Fóris, G; Fülöp, P; Kassai, A; Kosztáczky, B; Paragh, G; Seres, I; Varga, Z1
Hiramatsu, N; Hiromura, K; Ikeuchi, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakurai, N; Shigehara, T; Takeuchi, S; Tomioka, M1
Gao, P; Jia, R; Shui, H; Wu, X1
Jiang, L; Liang, ZG; Lin, X; Yao, H1

Trials

3 trial(s) available for angiotensin ii and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Angiotensin II-induced oxidative burst is fluvastatin sensitive in neutrophils of patients with hypercholesterolemia.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:9

    Topics: Aged; Angiotensin II; Calcium; Cells, Cultured; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Leukotriene C4; Male; Membrane Fluidity; Middle Aged; Neutrophils; Reactive Oxygen Species; Respiratory Burst; Signal Transduction; Vasoconstrictor Agents

2005
Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:6

    Topics: Adult; Angiotensin II; Anticholesteremic Agents; Blood Pressure; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Norepinephrine; Vasoconstrictor Agents

2006
Fluvastatin combined with benazepril may contribute to the favorable prognosis of patients with atrial fibrillation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83

    Topics: Angiotensin II; Atrial Fibrillation; Benzazepines; C-Reactive Protein; Case-Control Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Function Tests; Humans; Indoles; Interleukin-6; Kidney; Liver; Male; Middle Aged; Prognosis; Renin; Treatment Outcome; Tumor Necrosis Factor-alpha

2016

Other Studies

6 other study(ies) available for angiotensin ii and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Antioxidative effects of fluvastatin on superoxide anion activated by angiotensin II in human aortic smooth muscle cells.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:3

    Topics: Adult; Angiotensin II; Antioxidants; Aorta; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Male; Muscle, Smooth, Vascular; Simvastatin; Superoxides

2002
Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4

    Topics: Adrenomedullin; Angiotensin II; Animals; Aorta; Calcium; Diabetic Angiopathies; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; rho GTP-Binding Proteins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Life sciences, 2006, Aug-29, Volume: 79, Issue:14

    Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger

2006
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome.
    The Journal of membrane biology, 2006, Volume: 214, Issue:2

    Topics: Adult; Angiotensin I; Angiotensin II; Anticholesteremic Agents; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Homeostasis; Humans; Hypercholesterolemia; Indoles; Leukotriene C4; Male; Membrane Fluidity; Metabolic Syndrome; Middle Aged; Neutrophils; Pertussis Toxin; Protein Prenylation; Quinacrine; Signal Transduction; Superoxides; Vasoconstrictor Agents; Vasodilator Agents; Verapamil

2006
Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:8

    Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluorescent Antibody Technique; Fluvastatin; Genes, Wilms Tumor; Glomerulosclerosis, Focal Segmental; Immunoenzyme Techniques; Indoles; Kidney; Male; Membrane Proteins; Mice; Mice, Transgenic; Microfilament Proteins; Nephrectomy; Phenotype; Podocytes; Proteinuria

2009
Fluvastatin inhibits angiotensin II-induced nuclear factor kappa B activation in renal tubular epithelial cells through the p38 MAPK pathway.
    Molecular biology reports, 2012, Volume: 39, Issue:4

    Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; DNA; Electrophoretic Mobility Shift Assay; Epithelial Cells; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Kidney Tubules; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Rats

2012